552 related articles for article (PubMed ID: 29508278)
1. IL-23-induced macrophage polarization and its pathological roles in mice with imiquimod-induced psoriasis.
Hou Y; Zhu L; Tian H; Sun HX; Wang R; Zhang L; Zhao Y
Protein Cell; 2018 Dec; 9(12):1027-1038. PubMed ID: 29508278
[TBL] [Abstract][Full Text] [Related]
2. CX3CR1 deficiency attenuates imiquimod-induced psoriasis-like skin inflammation with decreased M1 macrophages.
Morimura S; Oka T; Sugaya M; Sato S
J Dermatol Sci; 2016 Jun; 82(3):175-88. PubMed ID: 26976687
[TBL] [Abstract][Full Text] [Related]
3. PSORI-CM02 formula alleviates imiquimod-induced psoriasis via affecting macrophage infiltration and polarization.
Li L; Zhang HY; Zhong XQ; Lu Y; Wei J; Li L; Chen H; Lu C; Han L
Life Sci; 2020 Feb; 243():117231. PubMed ID: 31887296
[TBL] [Abstract][Full Text] [Related]
4. IL-17A induces heterogeneous macrophages, and it does not alter the effects of lipopolysaccharides on macrophage activation in the skin of mice.
Nakai K; He YY; Nishiyama F; Naruse F; Haba R; Kushida Y; Katsuki N; Moriue T; Yoneda K; Kubota Y
Sci Rep; 2017 Sep; 7(1):12473. PubMed ID: 28963556
[TBL] [Abstract][Full Text] [Related]
5. 4-1BBL Regulates the Polarization of Macrophages, and Inhibition of 4-1BBL Signaling Alleviates Imiquimod-Induced Psoriasis.
Miki H; Han KH; Scott D; Croft M; Kang YJ
J Immunol; 2020 Apr; 204(7):1892-1903. PubMed ID: 32041783
[TBL] [Abstract][Full Text] [Related]
6. M2 polarization of murine peritoneal macrophages induces regulatory cytokine production and suppresses T-cell proliferation.
Oishi S; Takano R; Tamura S; Tani S; Iwaizumi M; Hamaya Y; Takagaki K; Nagata T; Seto S; Horii T; Osawa S; Furuta T; Miyajima H; Sugimoto K
Immunology; 2016 Nov; 149(3):320-328. PubMed ID: 27421990
[TBL] [Abstract][Full Text] [Related]
7. Involvement of M1 Macrophage Polarization in Endosomal Toll-Like Receptors Activated Psoriatic Inflammation.
Lu CH; Lai CY; Yeh DW; Liu YL; Su YW; Hsu LC; Chang CH; Catherine Jin SL; Chuang TH
Mediators Inflamm; 2018; 2018():3523642. PubMed ID: 30647534
[TBL] [Abstract][Full Text] [Related]
8. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
[TBL] [Abstract][Full Text] [Related]
9. M2-like macrophages polarized by Foxp3
Huang JH; Lin YL; Wang LC; Chiang BL
J Cell Mol Med; 2023 Jun; 27(11):1477-1492. PubMed ID: 37073709
[TBL] [Abstract][Full Text] [Related]
10. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
Ma L; Xue H; Qi R; Wang Y; Yuan L
J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
[TBL] [Abstract][Full Text] [Related]
11. SIRT3 alleviates imiquimod-induced psoriatic dermatitis through deacetylation of XBP1s and modulation of TLR7/8 inducing IL-23 production in macrophages.
Guo M; Zhuang H; Su Y; Meng Q; Liu W; Liu N; Wei M; Dai SM; Deng H
Front Immunol; 2023; 14():1128543. PubMed ID: 37275851
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-21 receptor signalling is not critically required for imiquimod-induced psoriasiform dermatitis in mice.
Kim HJ; Kim SH; Kim TG; Park JY; Lee M; Kim DS; Lee MG
Exp Dermatol; 2018 Feb; 27(2):191-195. PubMed ID: 29220875
[TBL] [Abstract][Full Text] [Related]
13. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway.
Di TT; Ruan ZT; Zhao JX; Wang Y; Liu X; Wang Y; Li P
Int Immunopharmacol; 2016 Mar; 32():32-38. PubMed ID: 26784569
[TBL] [Abstract][Full Text] [Related]
14. Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease.
Boutet MA; Bart G; Penhoat M; Amiaud J; Brulin B; Charrier C; Morel F; Lecron JC; Rolli-Derkinderen M; Bourreille A; Vigne S; Gabay C; Palmer G; Le Goff B; Blanchard F
Clin Exp Immunol; 2016 May; 184(2):159-73. PubMed ID: 26701127
[TBL] [Abstract][Full Text] [Related]
15. Imiquimod-induced psoriasis-like skin inflammation is suppressed by BET bromodomain inhibitor in mice through RORC/IL-17A pathway modulation.
Nadeem A; Al-Harbi NO; Al-Harbi MM; El-Sherbeeny AM; Ahmad SF; Siddiqui N; Ansari MA; Zoheir KM; Attia SM; Al-Hosaini KA; Al-Sharary SD
Pharmacol Res; 2015 Sep; 99():248-57. PubMed ID: 26149470
[TBL] [Abstract][Full Text] [Related]
16. Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1-high T cells.
Kim JH; Choi YJ; Lee BH; Song MY; Ban CY; Kim J; Park J; Kim SE; Kim TG; Park SH; Kim HP; Sung YC; Kim SC; Shin EC
J Allergy Clin Immunol; 2016 May; 137(5):1466-1476.e3. PubMed ID: 26824999
[TBL] [Abstract][Full Text] [Related]
17. Characterization and biological significance of IL-23-induced neutrophil polarization.
Li Y; Zhu L; Chu Z; Yang T; Sun HX; Yang F; Wang W; Hou Y; Wang P; Zhao Q; Tao Y; Zhang L; Zhang X; Zhao Y
Cell Mol Immunol; 2018 May; 15(5):518-530. PubMed ID: 28690333
[TBL] [Abstract][Full Text] [Related]
18. CD169
Li M; Yu W; Liu Z; Liu S
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891893
[TBL] [Abstract][Full Text] [Related]
19. MAD ointment ameliorates Imiquimod-induced psoriasiform dermatitis by inhibiting the IL-23/IL-17 axis in mice.
OuYang Q; Pan Y; Luo H; Xuan C; Liu J; Liu J
Int Immunopharmacol; 2016 Oct; 39():369-376. PubMed ID: 27540765
[TBL] [Abstract][Full Text] [Related]
20. Dihydroartemisinin Alleviates Imiquimod-Induced Psoriasis-like Skin Lesion in Mice Involving Modulation of IL-23/Th17 Axis.
Liu JM; Jin QX; Fujimoto M; Li FF; Jin LB; Yu R; Yan GH; Zhu LH; Meng FP; Zhang QG; Jin GH
Front Pharmacol; 2021; 12():704481. PubMed ID: 34483908
[No Abstract] [Full Text] [Related]
[Next] [New Search]
